These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2865281

  • 1. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report.
    Boczkowski JA, Zeichner A, DeSanto N.
    J Consult Clin Psychol; 1985 Oct; 53(5):666-71. PubMed ID: 2865281
    [No Abstract] [Full Text] [Related]

  • 2. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model].
    Gaebel W, Pietzcker A.
    Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719
    [No Abstract] [Full Text] [Related]

  • 3. [Can psycho-education of chronic schizophrenic patients have a short-term effect on drug-related attitude and behavior?].
    Hornung WP, Franzen U, Lemke R, Wiesemann C, Buchkremer G.
    Psychiatr Prax; 1993 Jul; 20(4):152-4. PubMed ID: 8103230
    [Abstract] [Full Text] [Related]

  • 4. [Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
    Mayer C, Soyka M.
    Fortschr Neurol Psychiatr; 1992 Jun; 60(6):217-22. PubMed ID: 1353747
    [Abstract] [Full Text] [Related]

  • 5. [The problem of drug compliance in schizophrenic patients].
    Albus M.
    Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
    [No Abstract] [Full Text] [Related]

  • 6. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings.
    Hornung WP, Kieserg A, Feldmann R, Buchkremer G.
    Patient Educ Couns; 1996 Dec; 29(3):257-68. PubMed ID: 9006241
    [Abstract] [Full Text] [Related]

  • 7. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W, Kilian R, Toumi M, Angermeyer MC.
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [Abstract] [Full Text] [Related]

  • 8. A German multicentre study on the long-term treatment of schizophrenic outpatients.
    Pietzcker A.
    Pharmacopsychiatry; 1985 Nov; 18(6):333-8. PubMed ID: 2868467
    [Abstract] [Full Text] [Related]

  • 9. [Applying Peplau's theory in improving drug compliance of a schizophrenic patient].
    Lan CM, Shiau SJ, Huang RY.
    Hu Li Za Zhi; 1997 Feb; 44(1):56-62. PubMed ID: 9355386
    [Abstract] [Full Text] [Related]

  • 10. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA, Burns T, Kemmler G, Fleischhacker WW.
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [Abstract] [Full Text] [Related]

  • 11. Enhancing medication use in schizophrenic patients.
    Diamond RJ.
    J Clin Psychiatry; 1983 Jun; 44(6 Pt 2):7-14. PubMed ID: 6133855
    [Abstract] [Full Text] [Related]

  • 12. Noncompliance in schizophrenia.
    Babiker IE.
    Psychiatr Dev; 1986 Jun; 4(4):329-37. PubMed ID: 2883650
    [Abstract] [Full Text] [Related]

  • 13. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
    Hornung WP, Schonauer K, Feldmann R, Mönking HS.
    Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
    [Abstract] [Full Text] [Related]

  • 14. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P, Degiovanni A, Parrot F.
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract] [Full Text] [Related]

  • 15. Negative symptoms of schizophrenia and compliance with medication.
    Tattan TM, Creed FH.
    Schizophr Bull; 2001 Apr; 27(1):149-55. PubMed ID: 11215543
    [Abstract] [Full Text] [Related]

  • 16. Compliance with medication but not structural MRI measures predict functional outcome in first-episode schizophrenia patients.
    Bachmann S, Bottmer C, Schröder J, Essig M, Magnotta V.
    Schizophr Res; 2007 Feb; 90(1-3):355-6. PubMed ID: 17222538
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance, evaluation, and management of secondary depression in schizophrenia.
    Becker RE, Singh MM, Meisler N, Shillcutt S.
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):26-32. PubMed ID: 2865254
    [Abstract] [Full Text] [Related]

  • 18. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP, Buchkremer G, Redbrake M, Klingberg S.
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [Abstract] [Full Text] [Related]

  • 19. Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
    Margetic B, Aukst-Margetic B.
    World J Biol Psychiatry; 2007 Jul; 8(2):131-2; author reply 133-4. PubMed ID: 17455107
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
    Kleinman I, Schachter D, Jeffries J, Goldhamer P.
    Hosp Community Psychiatry; 1993 Dec; 44(12):1189-91. PubMed ID: 7907571
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.